Skip Nav Destination
Issues
Journal Archive
Cancer Research (1941-Present; volumes 1-current)
(ISSN 0008-5472) Published twice monthly since 1987. From 1941-1986, published monthly.The American Journal of Cancer (1931-1940; volumes 15-40)
(ISSN 0099-7374) Published quarterly in 1931, bimonthly in 1932, and monthly from 1933 to 1940. The journal changed title to Cancer Research in 1941.The Journal of Cancer Research (1916-1930); volumes 1-14)
(ISSN 0099-7013) Published quarterly from 1916 through 1930 (publication was suspended from November 1922 to March 1924). The journal changed title to The American Journal of Cancer in 1931.Table of Contents
Advances in Brief
Frequent Silencing of Low Density Lipoprotein Receptor-Related Protein 1B (LRP1B) Expression by Genetic and Epigenetic Mechanisms in Esophageal Squamous Cell Carcinoma
Itaru Sonoda; Issei Imoto; Jun Inoue; Tatsuhiro Shibata; Yutaka Shimada; Koei Chin; Masayuki Imamura; Teruo Amagasa; Joe W. Gray; Setsuo Hirohashi; Johji Inazawa
Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival
Junichi Takamizawa; Hiroyuki Konishi; Kiyoshi Yanagisawa; Shuta Tomida; Hirotaka Osada; Hideki Endoh; Tomoko Harano; Yasushi Yatabe; Masato Nagino; Yuji Nimura; Tetsuya Mitsudomi; Takashi Takahashi
Presence of Simian Virus 40 DNA Sequences in Human Lymphoid and Hematopoietic Malignancies and Their Relationship to Aberrant Promoter Methylation of Multiple Genes
Narayan Shivapurkar; Takao Takahashi; Jyotsna Reddy; Yingye Zheng; Victor Stastny; Robert Collins; Shinichi Toyooka; Makato Suzuki; Gunjan Parikh; Sheryl Asplund; Steven H. Kroft; Charles Timmons; Robert W. McKenna; Ziding Feng; Adi F. Gazdar
Molecular Biology, Pathobiology, and Genetics
Genome-Wide Profiling of Papillary Thyroid Cancer Identifies MUC1 as an Independent Prognostic Marker
Volkert B. Wreesmann; Elizabeth M. Sieczka; Nicholas D. Socci; Michael Hezel; Thomas J. Belbin; Geoffrey Childs; Snehal G. Patel; Kepal N. Patel; Giovanni Tallini; Michael Prystowsky; Ashok R. Shaha; Dennis Kraus; Jatin P. Shah; Pulivarthi H. Rao; Ronald Ghossein; Bhuvanesh Singh
Overexpression, Amplification, and Androgen Regulation of TPD52 in Prostate Cancer
Mark A. Rubin; Sooryanarayana Varambally; Rameen Beroukhim; Scott A. Tomlins; Daniel R. Rhodes; Pamela L. Paris; Matthias D. Hofer; Martina Storz-Schweizer; Rainer Kuefer; Jonathan A. Fletcher; Bae-Li Hsi; Jennifier A. Byrne; Kenneth J. Pienta; Colin Collins; William R. Sellers; Arul M. Chinnaiyan
Regulation of p27Kip1 Protein Levels Contributes to Mitogenic Effects of the RET/PTC Kinase in Thyroid Carcinoma Cells
Donata Vitagliano; Francesca Carlomagno; Maria Letizia Motti; Giuseppe Viglietto; Yuri E. Nikiforov; Marina N. Nikiforova; Jerome M. Hershman; Anderson J. Ryan; Alfredo Fusco; Rosa Marina Melillo; Massimo Santoro
Cell and Tumor Biology
A Novel System for Simultaneous in Vivo Tracking and Biological Assessment of Leukemia Cells and ex Vivo Generated Leukemia-Reactive Cytotoxic T Cells
Martin G. Sauer; Marna E. Ericson; Brenda J. Weigel; Michael J. Herron; Angela Panoskaltsis-Mortari; Betsy T. Kren; Bruce L. Levine; Jon S. Serody; Carl H. June; Patricia A. Taylor; Bruce R. Blazar
Experimental Therapeutics, Molecular Targets, and Chemical Biology
Antitumor Activity of HKI-272, an Orally Active, Irreversible Inhibitor of the HER-2 Tyrosine Kinase
Sridhar K. Rabindran; Carolyn M. Discafani; Edward C. Rosfjord; Michelle Baxter; M. Brawner Floyd; Jonathan Golas; William A. Hallett; Bernard D. Johnson; Ramaswamy Nilakantan; Elsebe Overbeek; Marvin F. Reich; Ru Shen; Xiaoqing Shi; Hwei-Ru Tsou; Yu-Fen Wang; Allan Wissner
Apoptotic and Cytostatic Farnesyltransferase Inhibitors Have Distinct Pharmacology and Efficacy Profiles in Tumor Models
Veeraswamy Manne; Francis Y. F. Lee; David K. Bol; Johnni Gullo-Brown; Craig R. Fairchild; Louis J. Lombardo; Richard A. Smykla; Gregory D. Vite; Mei-Li D. Wen; Chiang Yu; Tai Wai Wong; John T. Hunt
Immunology
Immunoprevention of HER-2/neu Transgenic Mammary Carcinoma through an Interleukin 12-Engineered Allogeneic Cell Vaccine
Carla De Giovanni; Giordano Nicoletti; Lorena Landuzzi; Annalisa Astolfi; Stefania Croci; Alberto Comes; Silvano Ferrini; Raffaella Meazza; Manuela Iezzi; Emma Di Carlo; Piero Musiani; Federica Cavallo; Patrizia Nanni; Pier-Luigi Lollini
Endocrinology
Clinical Research
Epidemiology
Letters to the Editor
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.